in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharmaceutical Manufacture: Peptide Applications for Cardiovascular Therapies
2:30 PM MST | November 13, 2009 | Gary Hu, American Peptide Company
Gary Hu, American Peptide Company, VP Sales & Marketing A recent report by market and technology research firm Frost & Sullivan projected that the global peptide therapeutics market will be valued at nearly $2 billion by 2010, with Europe contributing more than a third, or $605 million, in a rapid development to meet the increasing need for new therapeutic approaches with peptides as active pharmaceutical ingredients (APIs). The peptide therapeutics market, according to Frost & Sullivan, is providing new commercial opportunities to life science...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee